TKL Research Services: Phase 1 Clinical Trials & Beyond

• Clinical pharmacology, Phases 1a and 1b
• Early efficacy, Phase 2a
• Pharmacokinetic profiling
• Proof of Concept (POC)
• Maximum tolerated dose
• Drug/drug interaction
• Bioavailability/bioequivalence, including single dose, multiple dose and food effect
• Normal healthy, specialized and/or disease-state populations

Learn more about HRIPT, cumulative irritation, photoxicity and photoallergy/photosensitization studies within our  Phase 1 Dermatology Clinical Trials services.